Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production

Journal of Cellular Biochemistry

Volumn 112, Issue 11, 2011, Pages 3167-3175

  Yefi, Roger ^a   Ponce, Daniela P ^a   Niechi, Ignacio ^a   Silva, Eduardo ^a   Cabello, Pablo ^a   Rodriguez, Diego A ^a   Marcelain, Katherine ^a   Armisen, Ricardo ^a   Quest, Andrew F G ^a   Tapia, Julio C ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

B CATENIN; CANCER; CK2; CYCLOOXYGENASE 2; PROSTAGLANDIN E2

Indexed keywords

2 DIMETHYLAMINO 4,5,6,7 TETRABROMO 1H BENZIMIDAZOLE; ANTIMITOTIC AGENT; BETA CATENIN; CASEIN KINASE II; CYCLOOXYGENASE 2; PROSTAGLANDIN E2; SC 791; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; HUMAN; HUMAN CELL; KIDNEY CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; BETA CATENIN; CASEIN KINASE II; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; UP-REGULATION;

EID: 80054973787     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23247     Document Type: Article

References (48)

1. Ahmed K, Gerber DA, Cochet C,. 2002. Joining the cell survival squad: An emerging role for protein kinase CK2. Trends Cell Biol 12: 226-230. (Pubitemid 34327615)
2. Altieri DC,. 2004. Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm. J Cell Biochem 92: 656-663. (Pubitemid 44264257)
3. Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, Miura K, Harris CC,. 2003. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 63: 728-734. (Pubitemid 36158154)
4. Beachy PA, Karhadkar SS, Berman DM,. 2004. Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324-331. (Pubitemid 39551660)
5. Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE,. 2007. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res 67: 11742-11750.
6. Blomme EA, Chinn KS, Hardy MM, Casler JJ, Kim SH, Opsahl AC, Hall WA, Trajkovic D, Khan KN, Tripp CS,. 2003. Selective cyclooxygenase-2 inhibition does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 mice. Br J Dermatol 148: 211-223. (Pubitemid 36278959)
7. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS,. 2005. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310: 1504-1510. (Pubitemid 41746348)
8. Castellone MD, Teramoto H, Gutkind JS,. 2006. Cyclooxygenase-2 and colorectal cancer chemoprevention: The beta-catenin connection. Cancer Res 66: 11085-11088. (Pubitemid 46009929)
9. Di Maira G, Salvi M, Arrigoni G, Marin O, Sarno S, Brustolon F, Pinna LA, Ruzzene M,. 2005. Protein kinase CK2 phosphorylates and upregulates Akt/PKB. Cell Death Differ 12: 668-677. (Pubitemid 40767169)
10. DuBois RN, Radhika A, Reddy BS, Entingh AJ,. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262. (Pubitemid 26113767)
11. Frolov RV, Ignatova II, Singh S,. 2010. Mechanism of K(v)2.1 channel inhibition by a selective COX-2 inhibitor SC-791-modification of gating. Brain Res 1359: 67-74.
12. Gao Y, Wang HY,. 2006. Casein kinase 2 is activated and essential for wnt/beta-catenin signaling. J Biol Chem 281: 18394-18400. (Pubitemid 44035497)
13. Guerra B, Issinger OG,. 1999. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20: 391-408. (Pubitemid 29125027)
14. Gupta RA, Dubois RN,. 2001. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1: 11-21. (Pubitemid 33741877)
15. Hardy MM, Blomme EA, Lisowski A, Chinn KS, Jones A, Harmon JM, Opsahl A, Ornberg RL, Tripp CS,. 2003. Selective cyclooxygenase-2 inhibition does not alter keratinocyte wound responses in the mouse epidermis after abrasion. J Pharmacol Exp Ther 304: 959-967. (Pubitemid 36254406)
16. Heeg-Truesdell E, LaBonne C,. 2006. Wnt signaling: A shaggy dogma tale. Curr Biol 16: R62-R64. (Pubitemid 43117425)
17. Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ, Trifan OC,. 1999. Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol 31: 551-557. (Pubitemid 29219401)
18. Kanaoka S, Takai T, Yoshida K,. 2007. Cyclooxygenase-2 and tumor biology. Adv Clin Chem 43: 59-78. (Pubitemid 44960960)
19. Kerbel RS,. 2008. Tumor angiogenesis. N Engl J Med 358: 2039-2049. (Pubitemid 351656458)
20. Kim SJ, Im DS, Kim SH, Ryu JH, Hwang SG, Seong JK, Chun CH, Chun JS,. 2002. Beta-catenin regulates expression of cyclooxygenase-2 in articular chondrocytes. Biochem Biophys Res Commun 296: 221-226.
21. Kimelman D, Xu W,. 2006. Beta-catenin destruction complex: Insights and questions from a structural perspective. Oncogene 25: 7482-7491. (Pubitemid 44885747)
22. Kobayashi T, Nakatani Y, Tanioka T, Tsujimoto M, Nakajo S, Nakaya K, Murakami M, Kudo I,. 2004. Regulation of cytosolic prostaglandin E synthase by phosphorylation. Biochem J 381: 59-69. (Pubitemid 38932211)
23. Krysan K, Dalwadi H, Sharma S, Pold M, Dubinett S,. 2004a. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res 64: 6359-6362. (Pubitemid 39297884)
24. Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Pold M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S,. 2004b. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J 18: 206-208.
25. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL, Prescott SM,. 1996. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci USA 93: 4816-4820. (Pubitemid 26162834)
26. Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC,. 2001a. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20: 3247-3257. (Pubitemid 32553677)
27. Landesman-Bollag E, Song DH, Romieu-Mourez R, Sussman DJ, Cardiff RD, Sonenshein GE, Seldin DC,. 2001b. Protein kinase CK2: Signaling and tumorigenesis in the mammary gland. Mol Cell Biochem 227: 153-165. (Pubitemid 34048380)
28. Litchfield DW,. 2003. Protein kinase CK2: Structure, regulation and role in cellular decisions of life and death. Biochem J 369: 1-15. (Pubitemid 36174119)
29. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T,. 2001. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276: 18563-18569.
30. Meggio F, Pinna LA,. 2003. One-thousand-and-one substrates of protein kinase CK2 ? FASEB J 17: 349-368. (Pubitemid 36292951)
31. Nagy JA, Dvorak AM, Dvorak HF,. 2007. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2: 251-275. (Pubitemid 46448066)
32. Pinna LA,. 2002. Protein kinase CK2: A challenge to canons. J Cell Sci 115: 3873-3878. (Pubitemid 35256488)
33. Ponce DP, Maturana JL, Cabello P, Yefi R, Niechi I, Silva E, Armisen R, Galindo M, Antonelli M, Tapia JC,. 2011. Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of beta-catenin transcriptional activity. J Cell Physiol 226: 1953-1959.
34. Rodriguez DA, Tapia JC, Fernandez JG, Torres VA, Munoz N, Galleguillos D, Leyton L, Quest AF,. 2009. Caveolin-1-mediated suppression of cyclooxygenase-2 via a {beta}-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. Mol Biol Cell 20: 2297-2310.
35. Segditsas S, Tomlinson I,. 2006. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537. (Pubitemid 44885752)
36. Seldin DC, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I,. 2005. CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol Cell Biochem 274: 63-67. (Pubitemid 41001501)
37. Shao J, Lee SB, Guo H, Evers BM, Sheng H,. 2003. Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res 63: 5218-5223. (Pubitemid 37139831)
38. Shao J, Jung C, Liu C, Sheng H,. 2005. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem 280: 26565-26572. (Pubitemid 41022254)
39. Tapia J, Jacob G, Allende CC, Allende JE,. 2002. Role of the carboxyl terminus on the catalytic activity of protein kinase CK2alpha subunit. FEBS Lett 531: 363-368. (Pubitemid 35341225)
40. Tapia JC, Bolanos-Garcia VM, Sayed M, Allende CC, Allende JE,. 2004. Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2. J Cell Biochem 91: 865-879.
41. Tapia JC, Torres VA, Rodriguez DA, Leyton L, Quest AF,. 2006. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc Natl Acad Sci USA 103: 15079-15084. (Pubitemid 44583167)
42. Tawfic S, Yu S, Wang H, Faust R, Davis A, Ahmed K,. 2001. Protein kinase CK2 signal in neoplasia. Histol Histopathol 16: 573-582. (Pubitemid 32297655)
43. Telliez A, Furman C, Pommery N, Henichart JP,. 2006. Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: Topical therapeutic strategies targeting COX-2 expression and activity. Anticancer Agents Med Chem 6: 187-208. (Pubitemid 43796638)
44. Torres VA, Tapia JC, Rodriguez DA, Parraga M, Lisboa P, Montoya M, Leyton L, Quest AF,. 2006. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J Cell Sci 119: 1812-1823. (Pubitemid 43811007)
45. Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF,. 2007. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef- dependent transcription. Mol Cell Biol 27: 7703-7717. (Pubitemid 350033675)
46. Tsujii M, Kawano S, DuBois RN,. 1997. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340. (Pubitemid 27157312)
47. Wang MT, Honn KV, Nie D,. 2007. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26: 525-534. (Pubitemid 350115125)
48. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM,. 2001. Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61: 8664-8667. (Pubitemid 34013874)